Philadelphia Inquirer reporter Stacey Burling interviewed Penn Memory Center research participants and clinicians in her article about the Anti-Amyloid Treatment in Asymptomatic Alzheimer’s (A4) Study, entitled “The risk of knowing: Alzheimer’s research volunteers.“
The A4 Study is a historic clinical trial to see if an experimental drug can protect healthy seniors whose brains harbor silent signs that they’re at risk. Ms. Burling spoke with Myrna Roach and Donald Jackson about why they chose to enroll in the study. She also spoke with Jason Karlawish, MD, associate director of the PMC about his A4 sub study which measures how disclosure of study participants’ amyloid status impacts them.
You can read the article here.
Interested in enrolling in the A4 study? Click here for more information.